News

Investors urged to act as potential XPEL claims are investigated

Investors urged to act as potential XPEL claims are investigated

Investors Urged to Seek Justice for Losses in XPEL

Faruqi & Faruqi, LLP’s Securities Litigation Partner James (Josh) Wilson is encouraging investors who have lost over $100,000 in XPEL to get in touch and explore their options.

If you’ve experienced losses exceeding $100,000 from investing in XPEL stock or its options and want to discuss your legal rights, feel free to reach out to Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Important Note: Investors should be aware that the deadline for stepping forward as a lead plaintiff in a federal securities class action against XPEL, Inc. is fast approaching on October 7, 2024. This investigation comes after recent allegations regarding XPEL's statements about its operations and reliance on the market.

Overview of the Investigation

Faruqi & Faruqi, LLP, a reputable national securities law firm, is currently investigating possible claims against XPEL, Inc. (NASDAQ: XPEL). The firm emphasizes the importance of taking action to protect investors’ interests.

Allegations indicate that XPEL might have made misleading or false statements about its dependence on essential suppliers and the competitive environment that hindered its growth. Reports indicate that XPEL’s market share has been under significant pressure from rival companies.

The Accusations Against XPEL

A particular report from Culper Research pointed out that XPEL has substantially understated its dependency on Tesla as a supplier. While XPEL claimed that only 5% of its revenue came from Tesla, findings suggest that the actual figure could be between 25% to 35% for its paint protection film business.

This inconsistency raises serious concerns about how transparent XPEL has been with investors regarding its key partnerships. The investigation will closely examine how XPEL has communicated its financial health amid these allegations.

Stock Market Reaction

After reports emerged about the potential misrepresentation of its supplier reliance, XPEL’s stock price fell sharply by $10.57, marking a drastic decline of over 17%, ultimately closing at $50.65. Furthermore, on May 2, 2024, XPEL released disappointing first-quarter results, missing profit estimates and altering its annual revenue forecast, which led to a stock price drop of $20.93, roughly 39%.

Options for Affected Investors

The lead plaintiff is usually the investor with the most significant financial interest in the class action who meets particular legal criteria. It’s vital for any investors in this situation to consider joining together for a more potent collective legal response.

Faruqi & Faruqi also encourages anyone with relevant information regarding XPEL’s practices—such as whistleblowers and former employees—to come forward and aid in the investigation.

How to Participate

If you want to learn more about the XPEL class action, you're welcome to contact the firm directly or check their official website for additional information. Speaking with a legal professional can help clarify your rights and the potential options available to you.

Stay connected for the latest updates about legal proceedings and investigation results by engaging in community discussions or following news related to Faruqi & Faruqi, LLP.

Frequently Asked Questions

What should I do if I invested in XPEL and incurred losses?

It's best to contact a securities litigation partner at Faruqi & Faruqi to talk about your situation and explore your legal options.

What is the deadline for filing a claim against XPEL?

The deadline for investors wishing to seek lead plaintiff status in the class action lawsuit is October 7, 2024.

How can I learn more about the XPEL investigation?

You can check out the official website of Faruqi & Faruqi or speak directly with their legal representatives for detailed information.

Can I join the class action if I didn’t lose more than $100,000?

Yes, you can still join the class action lawsuit even if your losses were less, though typically, the lead plaintiff must have substantial losses.

What types of evidence can strengthen my case against XPEL?

Relevant documents related to your investment, any communications from the company, and any records reflecting your financial losses will be beneficial.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 17

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 19

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 20

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 21

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 15

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 32

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 20

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 16

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 12

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 14

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex Completes Successful Share Buyback Initiative

Updated Category News Views 152

Ontex's Recent Treasury Share Acquisitions Ontex recently made a significant announcement regarding its share buyback program. In alignment with the Royal Decree executing the Belgian Code of Companies and Associations, the company shared details about its initiative to repurchase treasury shares. This action showcases Ontex's commitment to enhancing shareholder value....

Continue Reading
U.S. Stock Markets Climb to New Heights Amid Sector Gains

Updated Category News Views 232

U.S. Stock Markets Witness Significant Gains U.S. stocks displayed positive momentum as the trading session wrapped up. Various sectors, particularly Consumer Services, Healthcare, and Industrials, contributed to the overall market uptick. Investors welcomed the news of increased gains across these sectors, signaling robust performance in the face of economic challenges....

Continue Reading
Abeona Therapeutics Grants New Equity Awards to Employees

Updated Category News Views 131

Abeona Therapeutics Introduces New Employee Equity Grants CLEVELAND, a leading player in the biopharmaceutical sector, is making strides by enhancing its workforce through new employee equity grants. Abeona Therapeutics Inc. (Nasdaq: ABEO) has recently granted equity awards to new non-executive employees who have joined the company. This initiative aligns with their...

Continue Reading
Navigating Market Trends: Insights for Future Opportunities

Updated Category News Views 292

Analyzing Current Market Conditions As we dive into the second half of 2025, it’s the perfect time to reflect on the market's recent performance. A glance at key stock indices reveals intriguing patterns that could impact investment strategies moving forward. Trends in Major Indices The NASDAQ Composite recently reached a significant milestone, hitting a lifetime high...

Continue Reading
Celebrating Creative Achievements in Psychoanalysis: The Sigourney Award

Updated Category News Views 143

The Sigourney Award-2025 Recognizes Innovative Contributions The Sigourney Award-2025 has celebrated four outstanding recipients for their creative contributions that expand psychoanalytic thought on a global scale. This prestigious award is designed to recognize significant work that showcases the advancements and applications of psychoanalysis. The announcement was made...

Continue Reading